Patient correlates of patient-provider communication and financial toxicity in Black and White patients with cancer.

L Lauren M. Hamel (Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI) D David W. Dougherty (Penn Medicine-Abramson Cancer Center, Philadelphia, PA) S Seongho Kim (1Karmanos Cancer Institute, Detroit, United States) E Elisabeth I. Heath (Department of Medical Oncology, Mayo Clinic Rochester, Rochester, MN) L Lorna Mabunda (Karmanos Cancer Center, Wayne State University, Detroit, MI) T Teneisha Austin (Karmanos Cancer Center, Wayne State University, Detroit, MI) H Hadeel Assad (Barbara Ann Karmanos Cancer Institute, Detroit, MI) H Hirva Mamdani M Mohammed Najeeb Al Hallak (Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI) H Helda Bacall (Karmanos Cancer Center, Detroit, MI) A Adrienne Bouyer (Karmanos Cancer Institute, Detroit, MI) F Frank Cameron Cackowski (Karmanos Cancer Institute, Wayne State University, Detroit, MI) R Radhika Gogoi (Wayne State University/Karmanos Cancer Institute, Detroit, MI) E Erica Goldman (Karmanos Cancer Institute, Detroit, MI) I Ira Seth Winer (Division of Gynecologic Oncology, Department of Oncology, Wayne State University and Karmanos Cancer Center, Detroit, MI) E Eliza W. Beal (Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI) N Nouran Jarbo (Wayne State University, Detroit, MI) K Keri Angers (Wayne State University, Detroit, MI) S Susan Eggly (2Wayne State University Karmanos Cancer Institute, Detroit, United States)

Abstract

e13730 Background: Financial toxicity, the burden of treatment cost, affects up to half of people with cancer and can affect survival. Financial toxicity is a health equity issue, disproportionately affecting Black patients. This cross-sectional study used baseline data from the Discussions of Cost (DISCO) Trial, an RCT to improve patient-provider treatment cost discussions and, in turn, mitigate financial toxicity, to examine whether Black and White patients differed in patient-provider communication perceptions and financial toxicity correlates. Methods: Data were collected from 2021-2025 at an NCI-designated comprehensive cancer center. Participants were Black or White patients diagnosed with solid tumor cancers. At baseline, patients completed demographic measures; communication measures of self-efficacy in patient-provider interactions (e.g., “I am confident I know what questions to ask a provider”); self-efficacy in managing cancer treatment costs (e.g., “I am confident I can understand treatment costs”); and whether they have a provider- or patient-centered approach (e.g., “the provider should decide what gets talked about”); and financial measures including economic burden (e.g., “it’s difficult to live on my income”); treatment cost distress (e.g., “worries about paying for my cancer treatment keep me up at night”); and anticipated material hardship (e.g., “I worry about the financial problems I will have in the future as a result of my treatment”). Comparisons were conducted by patient race. Results: A total of 202 patients participated (116 Black patients, 86 White patients). White patients were more likely to have advanced degrees, a higher annual income, and less likely to have Medicaid compared to Black patients. Black patients reported higher self-efficacy for managing treatment costs ( p = .002) and a higher provider-focused orientation to the patient-provider relationship ( p = .001), than White patients. Black patients reported greater levels of financial burden ( p < .001), cost distress ( p = .005), and anticipated material hardship ( p = .003). There was no difference in self-efficacy for interacting with providers. Conclusions: These results suggest that a communication intervention for patients may help mitigate the experience of financial toxicity, especially for Black patients. Clinical trial information: NCT04766190 . Patient characteristics. Black Patients White Patients p -value Race 116 86 Education < High School High School/GED Some College 2 or 4-year College Degree Graduate/Professional College Trade/Technical/Vocational School 10352626712 0141631187 < .001 Annual Household Income 0 - $19,999 $20,000 - 39,999 $40,000 - 59,999 $60,000 - 79,999 $80,000 - 99,999 $100,000 - 149,999 $150,000 + 53201611431 51215991716 <.001 Insurance Type* Medicaid Medicare Medicare supplement Private None 604911330 113726393 <.001>.99<.001.20.15 *Patients could select more than one

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (19)

L

Lauren M. Hamel

Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI

D

David W. Dougherty

Penn Medicine-Abramson Cancer Center, Philadelphia, PA

S

Seongho Kim

1Karmanos Cancer Institute, Detroit, United States

E

Elisabeth I. Heath

Department of Medical Oncology, Mayo Clinic Rochester, Rochester, MN

L

Lorna Mabunda

Karmanos Cancer Center, Wayne State University, Detroit, MI

T

Teneisha Austin

Karmanos Cancer Center, Wayne State University, Detroit, MI

H

Hadeel Assad

Barbara Ann Karmanos Cancer Institute, Detroit, MI

H

Hirva Mamdani

M

Mohammed Najeeb Al Hallak

Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI

H

Helda Bacall

Karmanos Cancer Center, Detroit, MI

A

Adrienne Bouyer

Karmanos Cancer Institute, Detroit, MI

F

Frank Cameron Cackowski

Karmanos Cancer Institute, Wayne State University, Detroit, MI

R

Radhika Gogoi

Wayne State University/Karmanos Cancer Institute, Detroit, MI

E

Erica Goldman

Karmanos Cancer Institute, Detroit, MI

I

Ira Seth Winer

Division of Gynecologic Oncology, Department of Oncology, Wayne State University and Karmanos Cancer Center, Detroit, MI

E

Eliza W. Beal

Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI

N

Nouran Jarbo

Wayne State University, Detroit, MI

K

Keri Angers

Wayne State University, Detroit, MI

S

Susan Eggly

2Wayne State University Karmanos Cancer Institute, Detroit, United States